Work Here?
Overview
What Eli Health does: It builds a home hormone monitoring system for women’s reproductive health. How it works: a saliva sample is measured by a patent-pending point-of-care device, with a companion app that analyzes hormone data using algorithms to identify fertile days and overall reproductive health; consumables are required as part of a subscription. How it differs from competitors: it offers at-home, non-invasive hormone monitoring with a recurring subscription model and proprietary consumables, plus personalized insights from hormone data to guide conception or contraception decisions. What the goal is: to provide reliable, convenient reproductive health monitoring and decision support while creating a steady revenue stream through ongoing consumables and services.
About Eli Health
Industries
Consumer Software
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$17.8M
Headquarters
Montreal, Canada
Founded
2019
Your Connections
People at Eli Health who can refer or advise you
Simplify's Take
What believers are saying
- $12M Series A from BDC Capital funds manufacturing scale-up and biomarker expansion.
- CES 2025 Best of Innovation Award boosts credibility and media exposure.
- Subscription model at $8/test generates predictable recurring revenue from consumables.
What critics are saying
- LabCorp and Quest Diagnostics launch reimbursed saliva tests by late 2026, undercutting $8 pricing.
- FDA reclassifies Hormometer as Class II device in 9-15 months, delaying launches.
- Subscription churn exceeds 40% by Q4 2026 if users test under 2x monthly.
What makes Eli Health unique
- Hormometer uses saliva samples scanned by smartphone for instant cortisol and progesterone results.
- Achieves 80% agreement with lab-grade ELISA for salivary cortisol, surpassing snapshot tests.
- 12 patent-pending innovations in biochemistry, AI, and hardware create unique moat.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$17.8M
Below
Industry Average
Funded Over
5 Rounds
Industry standards
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 7%1 year growth
↑ 0%2 year growth
↑ 0%Canada's innovative tech products of 2025. News summary. In 2025, Canada showcased a variety of innovative tech products, highlighting its strong presence in the global consumer electronics market. Notable products include the Clicks keyboard cases, expanding from iPhone to Google Pixel and Motorola's Razr phones, spearheaded by Canadians Jeff Gadway and Kevin Michaluk. Ecobee, despite its acquisition by Generac Holdings, continued to lead with its Smart Thermostat Essential, integrating seamlessly with major smart home platforms. Eli Health, from Montreal, launched the Hormometer, a groundbreaking saliva-based hormone tester, while also securing a record $17-million Series A funding round for a Canadian women's health tech startup. Nanoleaf, originating from Toronto, introduced the affordable Smart Multicolour Floor Lamp, appealing to tech-savvy consumers. Vancouver-based Form Athletica released the Smart Swim 2 Pro goggles, enhancing aquatic workouts with advanced metrics. Fluance, a Canadian audio brand, presented its Ri71 Reference Stereo Powered Bookshelf Speakers, competing with industry giants. Toronto's InteraXon unveiled the Muse S Athena brain sensing headband, offering EEG and blood flow monitoring to improve mental wellness. Kobo, rooted in Toronto, offered the eco-friendly Clara Colour e-reader, challenging Amazon's Kindle. BlackBerry's QNX platform maintained a stronghold in the automotive industry, present in over 255 million cars worldwide. Finally, Haply Robotics from Montréal is set to release the MinVerse 3D mouse, targeting artists and designers in the XR space. Story coverage.
Eli Health closes $17-million CAD Series A to fuel launch of hormone-monitoring tech.
Eli Health raised $12M Series A led by BDC Capital's Thrive Venture Fund for its Hormometer, an instant hormone monitoring system. The New York-based company has raised $20M to date and plans a beta launch focusing on cortisol monitoring. The funds will aid production scaling, biomarker development, and platform expansion. Eli Health's device offers real-time hormone tracking via saliva samples and smartphone tech, with subscription plans starting at $8 per test.
The city has also raised its profile through companies like Eli Health, whose at-home hormone measurement technology won a CES 2025 award for innovation.
Canadian companies took home honours at the consumer trade show, but want more support
Eli Health is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Eli Health
Industries
Consumer Software
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$17.8M
Headquarters
Montreal, Canada
Founded
2019
Eli Health is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today